Texas Oncology - Central South
Clinical research site in Waco, Texas
Part of US Oncology
As of September 2026, 4 paid clinical trials are recruiting at Texas Oncology - Central South in Waco, Texas. Active studies at this site cover conditions such as Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma and Carcinoma, Renal Cell. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Texas Oncology - Central South (4)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Get new-trial alerts for Texas Oncology - Central South
We'll email you whenever a new clinical trial starts recruiting at this research site in Waco, TX. Unsubscribe anytime.
More research sites in Waco
- Velocity Clinical Research, Waco (5 trials)
- Baylor University (4 trials)
- GSK Investigational Site (3 trials)
- 89bio Clinical Study Site (2 trials)
- Akero Clinical Study Site (2 trials)
- Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX (2 trials)
- Digestive Research of Central Texas, LLC (2 trials)
- Objective Health-Digestive Research of Central Texas (2 trials)
- Texas Oncology - Central/South Texas (2 trials)
- Texas Oncology-Central South (2 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.